Dystrophin-glycoproteins associated in congenital muscular dystrophy: Immunohistochemical analysis of 59 Brazilian cases

Arquivos de Neuro-Psiquiatria

Volumn 63, Issue 3 B, 2005, Pages 791-800

  Gobbo Ferreira, Lucio ^a   Marie, Suely Kazue ^a   Liu, Enna Cristina ^b   Dutra Resende, Maria Bernadete ^a   Souza Carvalho, Mary ^a   Scaff, Milberto ^a   Conti Reed, Umbertina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Acadêmica da FMUSP ^*

Author keywords

Congenital muscular dystrophy; Dystroglycan complex; Dystrophin glycoproteins associated complex; Merosin; Sarcoglycan complex

Indexed keywords

ALPHA DYSTROGLYCAN; ALPHA SARCOGLYCAN; BETA DYSTROGLYCAN; DYSTROGLYCAN; DYSTROPHIN; GLYCOPROTEIN; MEROSIN; SARCOGLYCAN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOFIBROSIS; NEWBORN; PHENOTYPE; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; WALKER WARBURG SYNDROME;

EID: 27144438760     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2005000500014     Document Type: Article

References (45)

1. Tomé F. The saga of congenital muscular dystrophy. Neuropediatrics 1999;30:55-65.
2. Voit T. Congenital muscular dystrophies: 1997 update. Brain Dev 1998;20:65-74.
3. Muntoni F, Voit T. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul Disord 2004;14:635-649.
4. Helbling-Lecrerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Gen 1995;11:216-218.
5. Camacho Vanegas O, Bertini E, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci USA 2001;98:7516-7521.
6. Moghadaszadeh B, Petit N, Jaillard C, et al. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet 2001;29:17-18.
7. Brockington M, Yuva Y, Prandini P, et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 21 as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001;10:2851-2859.
8. Longman C, Brockington M, Torelli S, et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-DG. Hum Mol Genet 2003;12:2853-2861.
9. Toda T, Segawa M, Nomura Y, et al. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nature Genet 1993;5:283-286.
10. Yoshida A, Kobayashi K, Manya H, et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001;1:717-724.
11. Beltran-Valero De Bernabe D, Currier S, Steinbrecher A, et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002;71:1033-1043.
12. Brockington M, Sewry CA, Herrmann R, et al. Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42. Am J Hum Genet 2000;66:428-435.
13. Muntoni F. Journey into muscular dystrophies caused by abnormal glycosylation. Acta Myol 2004;23:79-84.
14. Muntoni F, Valero de Bernabe B, Bittner R, et al. 114th ENMC International Workshop on Congenital Muscular Dystrophy (CMD). Neuromusc Disord 2003;13:579-588.
15. Vainzof M, Zubrzycka-Gaarn EE, Rapaport MR, et al. Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxi-terminal and the amino-terminal region of the protein. J Neurol Sci 1991;101:141-147.
16. Hayashi YK, Engwall E, Arikawa-Hirasawa E, et al. Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sci 1993;119:53-64.
17. Agresti A. Categorial data analysis. New York: Wiley, 1990:588.
18. Pan TC, Zhang RZ, Sudano DG, Marie SK, Bonnemann CG, Chu ML. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Am J Hum Genet 2003;73:355-369.
19. Fardeau M, Tomé FMS, Helbling-Lecrerc A, et al. Dystrophie musculaire congénitale avec déficience en mérosine: analyse clinique, histopathologique, immunocytochimique et génétique. Rev Neurol 1996;152:11-19.
20. Jones KJ, Morgan G, Johnston H, et al. The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review. J Med Genet 2001;38:649-657.
21. Reed UC, Marie SK, Vainzof M, et al. Congenital muscular dystrophy with cerebral white matter hypodensity: correlation of clinical features and merosin deficiency. Brain Dev 1996;18:53-58.
22. Cohn RD, Herrmann R, Sorokin L, Wewer UM, Voit T. Laminin α2 chain-deficient congenital muscular dystrophy: variable epitope expression in severe and mild cases. Neurology 1998;5:94-101.
23. Sewry CA, Uziyel Y, Torelli S, et al. Differential labelling of laminin alpha 2 in muscle and neural tissue of dy/dy mice: are there isoforms of the laminin alpha 2 chain? Neuropathol Appl Neurobiol 1998;24:66-72.
24. Sewry CA, Philpot J, Mahony D, Wilson LA, Muntoni F, Dubowitz V. Expression of laminin subunits in congenital muscular dystrophy. Neuromusc Disord 1995;5:307-316.
25. Morandi L, Di Blasi C, Farina L, et al. Clinical correlations in 16 patients with total or partial laminin a2 deficiency characterized using antibodies against 2 fragments of the protein. Arch Neurol 1999;56:209-215.
26. Allamand V, Guicheney P. Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM# 156225, LAMA2 gene coding for alpha2 chain of laminin). Eur J Hum Genet 2002;10:91-94.
27. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002;82:291-329.
28. Vainzof M, Passos-Bueno MR, Canovas M, et al. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet 1996;5:1963-1969.
29. Shi W, Chen Z, Schottenfeld J, Stahl RC, Kunkel LM, Chan YM. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan. Muscle Nerve 2004;29:409-419.
30. Muntoni F, Bertini E, Bonnemann C, et al. 98th ENMC International Workshop on Congenital Muscular Dystrophy (CMD), 7th Workshop of the International Consortium on CMD, 2nd Workshop of the MYO CLUSTER project GENRE. Neuromusc Disord 2002;12:889-896.
31. Villanova M, Sabatelli P, He Y, et al. Immunofluorescence study of a muscle biopsy from a 1-year-old patient with Walker-Warburg syndrome. Acta Neuropathol (Berl) 1998;96:651-654.
32. Ibraghimov-Beskrovnaya O, Milatovich A, Ozcelik T, et al. Human DG: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet 1993;2:1651-1657.
33. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to extracellular matrix. Nature 1992;355:696-702.
34. ter Laak HJ, Leyten QH, Gabreels FJ, Kuppen H, Renier WO, Sengers RC. Laminin-alpha2 (merosin), beta-DG, alpha-sarcoglycan (adhalin), and dystrophin expression in congenital muscular dystrophies: an immunohistochemical study. Clin Neurol Neurosurg 1998;100:5-10.
35. Muntoni F, Brockington M, Blake DJ, Torelli S, Brown SC. Defective glycosylation in muscular dystrophy. Lancet 2002;360:1419-1421.
36. Michele DE, Barresi R, Kanagawa M, et al. Post-translational disruption of DG-ligand interactions in congenital muscular dystrophies. Nature 2002;418:417-422.
37. Endo T, Toda T. Glycosylation in congenital muscular dystrophies. Biol Pharm Bull 2003;26:1641-1647.
38. Tezak Z, Prandini P, Boscaro M, et al. Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha 2 (LAMA2) deficiency. Hum Mutat 2003;21:103-111.
39. Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 1989;32:195-210.
40. Beltran-Valero De Bernabe D, Currier S, Steinbrecher A, et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002;71:1033-1043.
41. Jimenez-Mallebrera C, Torelli S, Brown SC, et al. Profound skeletal muscle depletion of alpha-DG in Walker-Warburg syndrome. Eur J Paediatr Neurol 2003;7:129-137.
42. Mercuri E, Yuva Y, Brown SC, et al. Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. Neurology 2002;58:1354-1359.
43. Demir E, Sabatelli P, Allamand V, et al. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. Am J Hum Genet 2002;70:1446-1458.
44. Reed UC, Marie SK, Vainzof M, et al. Heterogeneity of classic congenital muscular dystrophy with involvement of the central nervous system: report of five atypical cases. J Child Neurol 2000;15:172-178.
45. Reed UC, Tsanaclis ANC, Vainzof M, et al. Merosin-positive congenital muscular dystrophy in two siblings with cataract and slight mental retardation. Brain Dev 1999;21:274-278.